Welcome to our dedicated page for Xylem SEC filings (Ticker: XYL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xylem Inc. filings document the regulatory disclosures of a public operating company focused on water solutions and resource management. Recent Form 8-K reports furnish quarterly and annual financial results, including press-release exhibits for orders, revenue, earnings measures and guidance-related disclosures.
Other Xylem filings record capital actions such as common-stock repurchase authorization, while definitive proxy materials cover governance, shareholder voting matters and executive compensation disclosures, including equity-award and pay-versus-performance information.
Xylem Inc. has filed an automatic shelf registration on Form S-3 to allow it to offer, from time to time after effectiveness, various securities, including debt securities, common stock, preferred stock, warrants, depositary shares, purchase contracts and units. Specific terms, amounts and prices will be set in future prospectus supplements.
The company states that net proceeds from any offering will be used for general corporate purposes, which may include debt repayment, share repurchases, dividends, acquisitions, investments, working capital and capital expenditures. The filing also outlines key indenture terms for future debt, including redemption, events of default, change‑of‑control repurchase rights and limitations on certain liens and sale‑leaseback transactions.
Xylem describes itself as a global water technology company serving utility, industrial, residential and commercial building markets across the water cycle. Its common stock trades on the New York Stock Exchange under the symbol “XYL.”
Xylem Inc. (XYL) insider filed a notice to sell common stock. The filing contemplates the sale of 4,778 common shares through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $562,481.45.
The shares were acquired as restricted stock vesting compensation from the issuer on several dates: 919 shares on 02/27/2023, 314 shares on 03/01/2023, 1,298 shares on 03/01/2024, and 2,247 shares on 03/01/2025.
Xylem Inc. reported higher results for the quarter ended June 30, 2026. Revenue was $2,336 million versus $2,301 million a year earlier, and net income attributable to Xylem was $263 million versus $226 million. Diluted EPS was $1.11, up from $0.93. For the first six months of 2026, revenue was $4,461 million versus $4,370 million, with net income attributable to Xylem of $456 million versus $395 million and diluted EPS of $1.90 versus $1.62. Operating income in Q2 rose to $390 million from $305 million, despite a $16 million loss on sale of businesses and higher income tax expense of $103 million.
Net cash provided by operating activities for the first half of 2026 was $398 million, compared with $338 million in 2025. Capital expenditures were $179 million, while investing activities used $98 million and financing activities used $484 million, including $990 million of new long-term debt and $1,243 million of common stock repurchases. Cash and cash equivalents were $1,276 million at June 30, 2026 versus $1,479 million at year-end, and total debt increased to $2,926 million from $1,942 million. Stockholders’ equity was $10,424 million.
Strategically, Xylem agreed to acquire WaterFleet Intermediate Holdings, Inc. for approximately $200 million and closed the acquisition of TriOS for €190 million (about $216 million). It completed the divestiture of its international metering business for total consideration of about $80 million, recognizing $14 million of a cumulative $37 million loss in 2026. As of June 30, 2026, remaining performance obligations under customer contracts totaled $2,924 million. Q2 restructuring and asset impairment charges were $11 million, and Xylem recorded $4 million of tariff refunds plus a $12 million receivable related to IEEPA tariff recoveries, reducing cost of revenue.
Xylem Inc. reported second-quarter 2026 revenue of $2.3 billion, up 2% on a reported basis and 1% organically. Orders were $3.1 billion, up 42% reported and 41% organically, indicating robust demand across its water infrastructure, industrial and services businesses.
Net income attributable to Xylem was $263 million, or $1.11 per diluted share, up 19%. Adjusted EPS was $1.46, up 16%. Net income margin increased 150 basis points to 11.3%, while adjusted EBITDA margin reached 23.3%, also up 150 basis points, helped by productivity savings, price realization and mix, more than offsetting inflation and lower volumes.
For the first half of 2026, net cash from operating activities was $398 million, supporting $179 million of capital expenditures and $1.243 billion of share repurchases, alongside $990 million of new long-term debt. Xylem now expects full-year 2026 revenue of about $9.2 billion, adjusted EBITDA margin of 23.1–23.5%, adjusted EPS of $5.55–$5.70, and free cash flow margin of 10.2–11.0%, reflecting management’s updated outlook for growth and profitability.
Xylem Inc. executive Joseph Patrick Johnston, EVP & President, AW, reported his initial ownership in a Form 3 filing. He directly holds 1,640 shares of common stock and several stock option grants with exercise prices between $86.76 and $129.67, expiring from 2032 through 2036. Some options and restricted stock units are already vested and exercisable, while others vest in staged increments from 2027 to 2029, outlining his long-term equity-based compensation.
Xylem Inc. executive Michael J. McGann, EVP & President, MCS, is identified as a reporting person in a Form 4 that shows no share purchases, sales, grants, exercises, gifts, or other insider transactions for this period. All transaction counts and reported holdings are zero, indicating no change in his ownership position.
Xylem Inc. completed a public debt offering of $500,000,000 aggregate principal amount of 5.200% Senior Notes due 2033 and $500,000,000 aggregate principal amount of 5.450% Senior Blue Notes due 2036. These senior unsecured notes rank equally with the company’s other unsecured, unsubordinated obligations and pay interest semiannually starting December 1, 2026.
Xylem plans to use the net proceeds from the 2033 Notes to repay or redeem $500 million of 3.250% Senior Notes maturing November 1, 2026 and for general corporate purposes. It intends to allocate an amount equal to the net proceeds from the 2036 Blue Notes to a portfolio of eligible blue projects, with unallocated amounts held in its treasury liquidity portfolio or other short-term liquid instruments.
Xylem Inc. is offering $1,000,000,000 aggregate principal amount of senior notes, consisting of $500,000,000 of 5.200% Senior Notes due 2033 and $500,000,000 of 5.450% Senior Blue Notes due 2036. The 2033 notes bear interest semi-annually and mature on June 1, 2033; the 2036 blue notes bear interest semi-annually and mature on June 1, 2036. Net proceeds from the 2033 notes are intended to repay the company’s $500 million 3.250% notes maturing November 1, 2026; net proceeds from the 2036 blue notes are intended to be allocated to a portfolio of Eligible Blue Projects as described in the Blue and Green Finance Framework, with unallocated proceeds held in the treasury liquidity portfolio or short-term instruments.
Xylem Inc. is offering two series of senior notes, including a labeled “blue” series whose net proceeds the company intends to allocate to a portfolio of Eligible Blue Projects under its Blue and Green Finance Framework. The company intends to use the proceeds from the non‑blue series to repay $500 million of 3.250% senior notes maturing on November 1, 2026.
The prospectus supplement describes customary terms for new senior unsecured notes, including interest payable semi‑annually, optional redemption mechanics, and a change‑of‑control repurchase right at 101% of principal plus accrued interest. Xylem discloses that allocation of proceeds to Eligible Blue Projects is intended but not contractually required and that related opinions and monitoring are supplemental and not part of the prospectus.
Xylem Inc. reported the results of its 2026 Annual Meeting of Shareholders. A total of 212,209,479 shares were represented, equal to 88.12% of common stock outstanding on March 19, 2026, meaning a high level of shareholder participation.
Shareholders elected nine directors, with each nominee receiving a strong majority of votes cast. For example, Earl R. Ellis received 199,588,485 votes for and 1,615,787 against, while all other nominees similarly achieved clear approval despite some variation in support levels.
Investors also ratified Deloitte & Touche LLP as independent auditor for 2026 with 205,386,746 votes for and 6,164,834 against. The advisory vote on named executive officer compensation passed with 176,623,615 votes for and 24,442,685 against. Shareholders further approved implementation of the Xylem Inc. 2026 Employee Stock Purchase Plan, with 200,869,123 votes for and 313,939 against.